Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news.

The June 2019 issue features:

• Director’s message: Prioritizing cancer research
  Federal cancer research funding is vital to meet growing challenges as the population ages.

• Predicting pancreatic cancer in patients with diabetes
  The UCP-1 gene may serve as a potential biomarker even before symptoms develop in high-risk groups.

• Study helps clarify role of T cells in follicular lymphoma
  The researchers' findings could lead to new treatments for this type of non-Hodgkin's lymphoma.

• Cervical cancer screening low, marked by racial disparity
  Mayo Clinic urges health professionals to find new ways to boost compliance with national guidelines.

• Study backs oxybutynin for hot flashes in breast cancer survivors
  Researchers say the drug improves quality of life in women who can't take hormone-based therapy.

• Oral blood clot drug safe, effective in patients with cancer
  Apixaban is easier to use than traditional blood thinners and has fewer side effects, research shows.

• Meet the investigator: Kabir Mody, M.D.
  In this Cancer Center video, Dr. Mody discusses research on pancreatic cancer and liver cancer.

View the online edition.

View the email newsletter.

Subscribe.

Tags: breast cancer, cervical cancer, diabetes, Kabir Mody, Mayo Clinic Cancer Center, News, non-Hodgkin lymphoma, pancreatic cancer